Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 27 (RPL7AP27)

Target: RPL7AP27
Molecular classification: Other (Processed pseudogene)

Overview

Ribosomal protein L7a pseudogene 27 (RPL7AP27) is a processed pseudogene in the human genome that is homologous to the functional RPL7A gene, which encodes a component of the 60S ribosomal subunit[6][8]. Pseudogenes are DNA sequences that derive from protein-coding genes but have lost their ability to encode functional products due to mutations or lack of regulatory elements. RPL7AP27 does not produce a functional protein, is not known to be involved in biological pathways, disease processes, or drug interactions, and is not considered a therapeutic or diagnostic target[6][8][7].

Other names: RPL7A_11_540RPL7AP27

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 27 (RPL7AP27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 27 (RPL7AP27).

Explore the full profile